(Report) Seminar “Solution for Global Health Issues -Public and Private Partnership-“
date : 11/5/2013
In recent years, there has been rapid economic growth in some developing countries which is seen as a new market opportunity for businesses, however, these
countries are disadvantaged by their limited access to medical resources. In particular they are significantly handicapped by the three major infectious
diseases i.e. HIV/AIDS, Tuberculosis, Malaria, and NTD (Neglected Tropical Diseases).
As public funding is limited, an innovative business model called “Public-Private-Partnership”(PPP) plays an important role in solving global health issues
in developing countries. PPP is a government service or private business venture which is funded and operated through a partnership of government and one or
more private sector companies.
In the first session of the current sequential seminars, we would like to hold discussion about why PPP has drawn great attention especially in the global
health field. By introducing examples of PPP by The Global Health Innovative Technology Fund (GHIT Fund,) which aims to solve global health issues, we
discussed how government and private sector companies can cooperate and maximize the partnership. The GHIT Fund is a non-profit organization aimed at
promoting the discovery and development of new health technologies including drugs, vaccines and diagnostics for infectious diseases prevalent in developing
counties.The first partnership of its kind in Japan, the GHIT Fund is a PPP established by the Government of Japan, a consortium of Japanese pharmaceutical
companies and the Bill & Melinda Gates Foundation in 2012. Through the session, we discussed and explored sustainable ways of contributing to global health
solutions with speakers and audience participation.
*Language: Japanese
■Date and Time
Oct 23, 2013 19:00-21:00
■Venue
ARK HILLS Club
37F East Wing, ARK Mori Building,
1-12-32 Akasaka, Minato-ku, Tokyo
■Theme
“Global Health and Public-Private Partnership”
■Speaker
-Kiyoshi Kurokawa
Professor, National Graduate Institute for Policy Studies / Chairman, Health and Global Policy Institute / Chair of the Board & Representative Director,
Global Health Innovative Technology Fund
-Kei Katsuno
Derector of Strategy, Global Health Innovative Technology Fund
■Fee
1,500 Yen (Student 1,000yen(Please show your school identification card.))
■Application Procedure
Please complete the online procedure on the Health and Global Policy Institute website by noon on Monday, Oct 21th, 2013. When the seats are fully booked,
we may stop accepting applications.
■Organizer
Health and Global Policy Institute
Since its establishment in 2004, the Health and Global Policy Institute (HGPI) has been working to help interested citizens shape health policies by
generating policy options and bringing stakeholders together as a nonpartisan think tank. HGPI’s mission is to improve civic and individual well-being and
to foster as sustainable healthy community by shaping ideas and values, reaching out to global needs, and catalyzing society for impact. HGPI commits to
activities that bring together relevant players in different fields to provide innovative and practical solutions and help interested citizens understand
choices and benefits in a global, long-term perspective. HGPI promotes a Global Citizen Nation by building a society for people with various backgrounds and
different values. It aims to achieve a sustainable, healthy, and more prosperous world.
Global Health Innovative Technology Fund
The Global Health Innovative Technology Fund (GHIT Fund) is Japan’s first public-private partnership to advance the development of new health technologies
for the developing world.
The first product development fund of its kind in Japan, the GHIT Fund was created by the Japanese Government, Japan’s leading pharmaceutical companies, and
the Bill & Melinda Gates Foundation.
The GHIT Fund is bringing Japanese leadership in health and technology innovation from its public and private sectors to the global fight against infectious
diseases. The goals is to facilitate and fund
global health R&D partnerships that can generate new drugs, vaccines and diagnostics and other tools for fighting neglected diseases prevalent in developing
world.
■Cooperated with
MORI HOSPITALITY CORPORATION
■Secretariat
Health and Global Policy Institute
Tel: 03-5511-8521
Email: info@hgpi.org
countries are disadvantaged by their limited access to medical resources. In particular they are significantly handicapped by the three major infectious
diseases i.e. HIV/AIDS, Tuberculosis, Malaria, and NTD (Neglected Tropical Diseases).
As public funding is limited, an innovative business model called “Public-Private-Partnership”(PPP) plays an important role in solving global health issues
in developing countries. PPP is a government service or private business venture which is funded and operated through a partnership of government and one or
more private sector companies.
In the first session of the current sequential seminars, we would like to hold discussion about why PPP has drawn great attention especially in the global
health field. By introducing examples of PPP by The Global Health Innovative Technology Fund (GHIT Fund,) which aims to solve global health issues, we
discussed how government and private sector companies can cooperate and maximize the partnership. The GHIT Fund is a non-profit organization aimed at
promoting the discovery and development of new health technologies including drugs, vaccines and diagnostics for infectious diseases prevalent in developing
counties.The first partnership of its kind in Japan, the GHIT Fund is a PPP established by the Government of Japan, a consortium of Japanese pharmaceutical
companies and the Bill & Melinda Gates Foundation in 2012. Through the session, we discussed and explored sustainable ways of contributing to global health
solutions with speakers and audience participation.
*Language: Japanese
■Date and Time
Oct 23, 2013 19:00-21:00
■Venue
ARK HILLS Club
37F East Wing, ARK Mori Building,
1-12-32 Akasaka, Minato-ku, Tokyo
■Theme
“Global Health and Public-Private Partnership”
■Speaker
-Kiyoshi Kurokawa
Professor, National Graduate Institute for Policy Studies / Chairman, Health and Global Policy Institute / Chair of the Board & Representative Director,
Global Health Innovative Technology Fund
-Kei Katsuno
Derector of Strategy, Global Health Innovative Technology Fund
■Fee
1,500 Yen (Student 1,000yen(Please show your school identification card.))
■Application Procedure
Please complete the online procedure on the Health and Global Policy Institute website by noon on Monday, Oct 21th, 2013. When the seats are fully booked,
we may stop accepting applications.
■Organizer
Health and Global Policy Institute
Since its establishment in 2004, the Health and Global Policy Institute (HGPI) has been working to help interested citizens shape health policies by
generating policy options and bringing stakeholders together as a nonpartisan think tank. HGPI’s mission is to improve civic and individual well-being and
to foster as sustainable healthy community by shaping ideas and values, reaching out to global needs, and catalyzing society for impact. HGPI commits to
activities that bring together relevant players in different fields to provide innovative and practical solutions and help interested citizens understand
choices and benefits in a global, long-term perspective. HGPI promotes a Global Citizen Nation by building a society for people with various backgrounds and
different values. It aims to achieve a sustainable, healthy, and more prosperous world.
Global Health Innovative Technology Fund
The Global Health Innovative Technology Fund (GHIT Fund) is Japan’s first public-private partnership to advance the development of new health technologies
for the developing world.
The first product development fund of its kind in Japan, the GHIT Fund was created by the Japanese Government, Japan’s leading pharmaceutical companies, and
the Bill & Melinda Gates Foundation.
The GHIT Fund is bringing Japanese leadership in health and technology innovation from its public and private sectors to the global fight against infectious
diseases. The goals is to facilitate and fund
global health R&D partnerships that can generate new drugs, vaccines and diagnostics and other tools for fighting neglected diseases prevalent in developing
world.
■Cooperated with
MORI HOSPITALITY CORPORATION
■Secretariat
Health and Global Policy Institute
Tel: 03-5511-8521
Email: info@hgpi.org
Exhibition date：2013-10-23
Top Research & Recommendations Posts
- [Research Report] Survey of Japanese Physicians Regarding Climate Change and Health (December 3, 2023)
- [Research Paper] “Rethinking Japan’s Health System Sustainability Under the Planetary Health Framework” Published in Health Systems & Reform (November 21, 2023)
- [Announcement] HGPI Joins Call for “Global Health and Medical Community Unite To Demand End Fossil Fuel Dependency at COP28” (November 1, 2023)
- [Announcement] HGPI Endorsed “For the Health of People and Planet: Priorities for a Healthy COP28” (November 30, 2023)
- [Research Report] The Public Opinion Survey on Child-Rearing in Modern Japan (Final Report) (March 4, 2022)
- [Policy Recommendations] Coming Together to Protect and Foster: Promoting Innovative and Sustainable Planetary Health in the Asia-Pacific Region to Build Resilient Health Systems (November 29, 2023)
- [Research Report] Building a Mental Health Program for Children and Measuring its Effectiveness (June 16, 2022）
- [Activity Report] HGPI Submits Requests for the G7 Hiroshima Summit to the G7 Sous-Sherpa (December 23, 2022)
- [Public Comment Submission] Ministry of Foreign Affairs “Call for Opinions on the Draft Revisions to the Guidelines for the Implementation of the Sustainable Development Goals (SDGs)” (November 22, 2023)
- [Urgent Recommendations] The Kidney Disease Control Promotion Project – Establishing Kidney Disease Control Measures with Patient, Citizen, and Community Engagement and Collaboration: Recommendations for Current Issues and Topics in Kidney Disease Control (May 11, 2022)
Featured Posts
-
2023-10-31
[Registration Open] Online Public Symposium “Dementia Risk Reduction: How Society Should Face the Individualization of Risk” (December 12, 2023)
![[Registration Open] Online Public Symposium “Dementia Risk Reduction: How Society Should Face the Individualization of Risk” (December 12, 2023)](https://hgpi.org/en/wp-content/uploads/sites/2/dementia-20231212-top-1.png)
-
2023-12-03
[Research Report] Survey of Japanese Physicians Regarding Climate Change and Health (December 3, 2023)
![[Research Report] Survey of Japanese Physicians Regarding Climate Change and Health (December 3, 2023)](https://hgpi.org/en/wp-content/uploads/sites/2/cop28_JPN_Survey.png)
-
2023-12-04
[Registration Open] (Webinar) The 122nd HGPI Seminar: Keeping Pace with Growing Diversity of Health Information in Health Communication (December 19, 2023)
![[Registration Open] (Webinar) The 122nd HGPI Seminar: Keeping Pace with Growing Diversity of Health Information in Health Communication (December 19, 2023)](https://hgpi.org/en/wp-content/uploads/sites/2/hs-122-top_JPNENG-1-1.png)
-
2023-12-05
[Policy Recommendations] Recommendation: Suggestions for Building a Resilient and Greener Health Care System Considering Sustainability and Environmental Concerns in the Revision of Medical, Nursing Care, and Disability Welfare Service Fees (December 6, 2023)
![[Policy Recommendations] Recommendation: Suggestions for Building a Resilient and Greener Health Care System Considering Sustainability and Environmental Concerns in the Revision of Medical, Nursing Care, and Disability Welfare Service Fees (December 6, 2023)](https://hgpi.org/en/wp-content/uploads/sites/2/d437afe0aebbdf1b837eae29b0db618d.png)
-
2023-12-05
[Registration Open] Online Global Expert Meeting: Considering Participation Among People Living with Dementia in the Formulation of National Dementia Strategies and in Policy Making Processes (January 22, 2024)
![[Registration Open] Online Global Expert Meeting: Considering Participation Among People Living with Dementia in the Formulation of National Dementia Strategies and in Policy Making Processes (January 22, 2024)](https://hgpi.org/en/wp-content/uploads/sites/2/dementia-20240122-top_JPNENG.png)
